[Research impulses for personalized cancer therapies].
出版信息
Aktuelle Urol. 2013 Sep;44(5):349. doi: 10.1055/s-0033-1353705. Epub 2013 Sep 16.
PMID:24043531
Abstract
摘要
相似文献
1
[Research impulses for personalized cancer therapies].[个性化癌症治疗的研究动力]
Aktuelle Urol. 2013 Sep;44(5):349. doi: 10.1055/s-0033-1353705. Epub 2013 Sep 16.
2
Importance of fundamental science as the cornerstone for translational research.基础科学作为转化研究基石的重要性。
BJU Int. 2016 Feb;117(2):205. doi: 10.1111/bju.13391.
3
[Securing the future through research - light on the horizon?].[通过研究确保未来——曙光在前？]
Urologe A. 2011 Aug;50(8):932-7. doi: 10.1007/s00120-011-2544-4.
4
[Intratumoral heterogeneity in renal cell carcinoma. Molecular basis and translational implications].[肾细胞癌的肿瘤内异质性。分子基础及转化意义]
Urologe A. 2015 Jun;54(6):800-3. doi: 10.1007/s00120-015-3800-9.
5
What's new in renal cell carcinoma.肾细胞癌有哪些新进展。
Bull Am Coll Surg. 2012 Aug;97(8):65-6.
6
From bench to bedside: does preclinical practice in translational oncology need some rebuilding?从实验台到病床边：转化肿瘤学的临床前实践是否需要重新构建？
J Natl Cancer Inst. 2013 Oct 2;105(19):1426-7. doi: 10.1093/jnci/djt253. Epub 2013 Sep 19.
7
Predictors of response to targeted therapy in renal cell carcinoma.肾细胞癌靶向治疗反应的预测因素。
Arch Pathol Lab Med. 2012 May;136(5):490-5. doi: 10.5858/arpa.2010-0308-RA. Epub 2012 Jan 9.
8
Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine.透明细胞肾肿瘤的鉴别诊断：靶向治疗和个性化医学时代肾肿瘤分类的临床意义。
Arch Pathol Lab Med. 2013 Apr;137(4):467-80. doi: 10.5858/arpa.2012-0085-RA.
9
Personalized oncology: recent advances and future challenges.个性化肿瘤学：最新进展与未来挑战。
Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19.
10
[On course for knowledge-based and individualized medicine. 63rd Congress of the German Society for Urology].[迈向基于知识的个性化医学。德国泌尿外科学会第63届大会]
Urologe A. 2011 Sep;50 Suppl 1:5-6. doi: 10.1007/s00120-011-2642-3.
Zotero 插件